Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) performance in progressive supranuclear palsy and multiple system atrophy

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Journal of neural transmission

• Publication date

  2016-06-22

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1007/s00702-016-1589-3PMID 27334897
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• MMSE and MoCA in Parkinson’s disease and dementia with Lewy bodies: a multicenter 1-year follow-up study

  2016cited by this paper
• Diagnosing dementia in multiple system atrophy by applying Movement Disorder Society diagnostic criteria for Parkinson's disease dementia.

  2015cited by this paper
• The frontal assessment battery is not useful to discriminate progressive supranuclear palsy from frontotemporal dementias.

  2015influential reference
• Cognition in corticobasal syndrome and progressive supranuclear palsy: A review

  2014cited by this paper
• The Addenbrooke's Cognitive Examination for the differential diagnosis and longitudinal assessment of patients with parkinsonian disorders

  2013influential reference
• A cross-sectional multicenter study of cognitive and behavioural features in multiple system atrophy patients of the parkinsonian and cerebellar type

  2013cited by this paper
• Are Frontal Cognitive and Atrophy Patterns Different in PSP and bvFTD? A Comparative Neuropsychological and VBM Study

  2013cited by this paper
• Cognitive testing in the diagnosis of parkinsonian disorders: A critical appraisal of the literature

  2012cited by this paper
• The Montreal Cognitive Assessment as a screening tool for cognitive dysfunction in Huntington's disease

  2010cited by this paper
• CSF Aβ42 and tau in Parkinson's disease with cognitive impairment

  2010cited by this paper
• Mini Mental State

  2010cited by this paper
• Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy.

  2010cited by this paper
• Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease

  2009influential reference
• Cross validation of the Montreal Cognitive Assessment in community dwelling older adults residing in the Southeastern US

  2009cited by this paper
• Subcortical structures and cognition

  2009cited by this paper
• The montreal cognitive assessment as a screening tool for cognitive impairment in Parkinson's disease

  2008cited by this paper
• Second consensus statement on the diagnosis of multiple system atrophy

  2008cited by this paper
• Cognitive and behavioral assessment in the early stages of neurodegenerative extrapyramidal syndromes.

  2008cited by this paper
• A comparison of the mini mental state exam to the montreal cognitive assessment in identifying cognitive deficits in Parkinson's disease

  2008influential reference
• Subcortical Structures and Cognition: Implications for Neuropsychological Assessment

  2008cited by this paper
• Visuospatial functions in atypical parkinsonian syndromes

  2006cited by this paper
• Comparison of motor, cognitive, and behavioral features in progressive supranuclear palsy and Parkinson's disease

  2006cited by this paper
• Can the frontal assessment battery (FAB) differentiate bradykinetic rigid syndromes? Relation of the FAB to formal neuropsychological testing

  2005cited by this paper
• Subcortical dementia revisited: Similarities and differences in cognitive function between progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and multiple system atrophy (MSA)

  2005cited by this paper
• Cognitive bedside assessment in atypical parkinsonian syndromes

  2005cited by this paper
• The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment

  2005influential reference
• A meta-analytic review of verbal fluency performance following focal cortical lesions.

  2004cited by this paper
• Executive function differences in multiple system atrophy and Parkinson's disease.

  2003cited by this paper
• Performance on the dementia rating scale in Parkinson’s disease with dementia and dementia with Lewy bodies: comparison with progressive supranuclear palsy and Alzheimer’s disease

  2003cited by this paper
• Differentiation of parkinsonian syndromes according to differences in executive functions

  2003influential reference
• Neuropsychological follow up in patients with Parkinson's disease, striatonigral degeneration-type multisystem atrophy, and progressive supranuclear palsy

  2000influential reference
• Diagnostic criteria for Parkinson disease.

  1999cited by this paper
• The effects of focal anterior and posterior brain lesions on verbal fluency

  1998cited by this paper
• Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome)

  1996cited by this paper
• Attentional functions in multiple system atrophy and Parkinson's disease.

  1996cited by this paper
• Neuropsychological pattern of striatonigral degeneration: comparison with Parkinson's disease and progressive supranuclear palsy.

  1995cited by this paper
• Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach.

  1988influential reference
• “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician

  1975cited by this paper
• Index for rating diagnostic tests

  1950cited by this paper

• Differences in the profile of mild cognitive impairment among inpatients with T2DM: a comparison of the MMSE and MoCA.

  2026cites this paper
• A Short Cognitive and Neuropsychiatric Assessment Scale for Progressive Supranuclear Palsy

  2025cites this paper
• Detecting amyloid and tau pathology in Parkinson’s disease, 4R-tauopathies and control subjects with plasma pTau217

  2025cites this paper
• Optimal cut-off scores for the Mini Mental State Examination and Montreal Cognitive Assessment to detect MCI and dementia in Multiple System Atrophy.

  2025cites this paper
• Language impairment is associated with faster progression in progressive supranuclear palsy‐Richardson syndrome

  2025cites this paper
• Monash-Alfred protocol for assessment of atypical parkinsonian syndromes (MAP-APS)

  2024cites this paper
• Dominance of Tau Burden in Cortical Over Subcortical Regions Mediates Glymphatic Activity and Clinical Severity in PSP

  2024cites this paper
• The discriminative linguistic profiles of progressive supranuclear palsy and Parkinson's disease.

  2024cites this paper
• Montreal cognitive assessment as a cognitive outcome measure in progressive supranuclear palsy

  2024cites this paper
• Optimal MMSE and MoCA cutoffs for cognitive diagnoses in Parkinson's disease: A data-driven decision tree model.

  2024cites this paper
• The Impact of Fatigue on Sleep and Other Non-Motor Symptoms in Parkinson’s Disease

  2024cites this paper
• Uncovering spatiotemporal patterns of atrophy in progressive supranuclear palsy using unsupervised machine learning

  2023cites this paper
• Sentence completion in progressive supranuclear palsy following transcranial direct current stimulation

  2023cites this paper
• The Relationship between Physical Fitness and Cognitive Functions in Older People: A Systematic Review

  2023cites this paper
• Retinal Thinning as a Marker of Disease Severity in Progressive Supranuclear Palsy

  2023cites this paper
• Analysis of Genetic and MRI Changes, Blood Markers, and Risk Factors in a Twin Pair Discordant of Progressive Supranuclear Palsy

  2023cites this paper
• C-STIM: Protocol for a randomized, single-blind, crossover study of cerebellar repetitive transcranial magnetic stimulation (rTMS) for postural instability in people with progressive supranuclear palsy (PSP)

  2023cites this paper
• Nocturia and Sleep in Parkinson’s Disease

  2023cites this paper
• Restless Legs Syndrome in Parkinson’s Disease

  2023cites this paper
• Clinical, cognitive, and morphometric profiles of progressive supranuclear palsy phenotypes

  2023cites this paper
• The Strengths and Obstacles in the Differential Diagnosis of Progressive Supranuclear Palsy—Parkinsonism Predominant (PSP-P) and Multiple System Atrophy (MSA) Using Magnetic Resonance Imaging (MRI) and Perfusion Single Photon Emission Computed Tomography (SPECT)

  2022cites this paper
• Alterations of voxel‐wise spontaneous activity and corresponding brain functional networks in multiple system atrophy patients with mild cognitive impairment

  2022cites this paper
• The Cognitive Profile of Atypical Parkinsonism: A Meta-Analysis

  2022cites this paper
• Optimization of cognitive assessment in Parkinsonisms by applying artificial intelligence to a comprehensive screening test

  2022cites this paper
• Personalized Assessment of Insomnia and Sleep Quality in Patients with Parkinson’s Disease

  2022cites this paper
• Longitudinal changes of early motor and cognitive symptoms in progressive supranuclear palsy: the OxQUIP study

  2022cites this paper
• The contribution of beta-amyloid to dementia in Lewy body diseases: a 1-year follow-up study

  2021cites this paper
• Laboratory‐Supported Multiple System Atrophy beyond Autonomic Function Testing and Imaging: A Systematic Review by the MoDiMSA Study Group

  2021cites this paper
• Descripción de los resultados de las pruebas neuropsicológicas en el diagnóstico diferencial de los pacientes con Alzheimer

  2021cites this paper
• Parkinson’s Disease in Romania: A Scoping Review

  2021cites this paper
• Clinical progression of progressive supranuclear palsy: impact of trials bias and phenotype variants

  2021cites this paper
• Montreal Cognitive Assessment as Screening Measure for Mild and Major Neurocognitive Disorder in a Chilean Population

  2020cites this paper
• Huntington’s Disease

  2020cites this paper
• Alzheimer’s Dementia

  2020cites this paper
• The effect of nonpharmacologic therapy on global cognitive functions in patients with Alzheimer’s disease: an updated meta-analysis of randomized controlled trials

  2020cites this paper
• Fluência verbal de adultos e idosos do Distrito Federal: proposta normativa piloto

  2020cites this paper
• Early autonomic and cognitive dysfunction in PD, DLB and MSA: blurring the boundaries between α-synucleinopathies

  2020cites this paper
• Parkinson’s Disease Dementia

  2020cites this paper
• Answers to Exercises

  2020cites this paper
• Bibliography

  2020cites this paper
• Preface

  2020cites this paper
• Index

  2020cites this paper
• Glossary

  2020cites this paper
• Test Protocol

  2020cites this paper
• Test Material

  2020cites this paper
• Association of orthostatic blood pressure with the symptoms of orthostatic hypotension and cognitive impairment in patients with multiple system atrophy.

  2020cites this paper
• Effect of mirabegron on cognitive function in elderly patients with overactive bladder: MoCA results from a phase 4 randomized, placebo-controlled study (PILLAR)

  2020cites this paper
• Cognition in multiple system atrophy: a single‐center cohort study

  2020cites this paper
• The Progressive Supranuclear Palsy Clinical Deficits Scale

  2020cites this paper
• Differences in cognitive profiles between Lewy body and Parkinson’s disease dementia

  2020cites this paper
• Language in Dementia

  2020cites this paper
• Vascular Dementia

  2020cites this paper
• The cognitive profile and executive function of progressive supranuclear palsy and multiple system atrophy patients

  2019cites this paper
• Language impairment in progressive supranuclear palsy and corticobasal syndrome

  2019cites this paper
• Factor structure of the Montreal Cognitive Assessment in Parkinson disease

  2019cites this paper
• Characteristics and progression of cognitive deficits in progressive supranuclear palsy vs. multiple system atrophy and Parkinson’s disease

  2019cites this paper
• Movement Disorders with Dementia in Older Adults

  2019cites this paper
• Claustral structural connectivity and cognitive impairment in drug naïve Parkinson’s disease

  2018cites this paper
• Brain morphological alteration and cognitive dysfunction in multiple system atrophy.

  2018cites this paper
• Sensitivity and Specificity of the ECAS in Parkinson's Disease and Progressive Supranuclear Palsy

  2018cites this paper
• University of Dundee Sensitivity and specificity of the ECAS in Parkinson’s disease and Progressive Supranuclear Palsy

  2018cites this paper
• Long-term treatment with rotigotine in drug-naïve PSP patients

  2018cites this paper
• Brain structural profile of multiple system atrophy patients with cognitive impairment

  2017cites this paper
• Divergent Thinking in Parkinsonism: A Case–Control Study

  2017cites this paper
• ----------------------------------------------------------------------------------------------------------------------------- -

  2017cites this paper
• Measuring stability of cognitive impairment in inpatients with schizophrenia with alternate forms of the Montreal Cognitive Assessment during acute hospitalization.

  2017cites this paper
• Recent advances in neuropathology, biomarkers and therapeutic approach of multiple system atrophy

  2017cites this paper
• Cognitive impairment in multiple system atrophy

  2017cites this paper
• Evaluación del Mini Cog comparado con el mini examen del estado mental modificado utilizado por el Ministerio de Salud Pública para tamizaje de deterioro cognitivo en el primer nivel de atención en la parroquia de Yaruquí

  2017cites this paper
• Differentiation of atypical Parkinson syndromes

  2017cites this paper
• Progressive supranuclear palsy

  2015cites this paper
• Mild Cognitive Impairment

  2008cites this paper